By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ApoCell, Inc. 

2575 West Bellfort
Suite 190
Houston  Texas  77054  U.S.A.
Phone: 713-440-6070 Fax: 713-440-6074



Company News
Cancer Genetics (CGIX) And ApoCell, Inc. Announce Partnership Focused On Transforming Cancer Profiling & Therapy Selection Leveraging Proprietary, High-Performance, Liquid Biopsy Platform For Rare Cell Capture And Detection 9/26/2016 7:38:55 AM
ApoCell, Inc. Entering the Commercial Ring In Rare Tumor Cell Diagnostics 12/27/2013 6:53:19 AM
ApoCell, Inc. Receives $1 Million SBIR Contract To Develop A Point-of-Care Clinical Device For Circulating Tumor Cell (CTC) Isolation 11/13/2013 9:43:08 AM
ApoCell, Inc. Expands Into Europe, Establishes Laboratory In Germany And Partners With The Fraunhofer Institute for Cell Therapy and Immunology 11/11/2013 9:33:20 AM
Transgenomic, Inc. (TBIO) and ApoCell, Inc. Present Results of Lung Cancer Research Study at the 2013 American Society of Clinical Oncology Annual Meeting 6/3/2013 9:19:22 AM
ApoCell, Inc. Announces Delivery of First Prototypes of ApoStream™ Circulating Tumor Cell (CTC) Isolation Technology to National Cancer Institute 5/16/2013 9:14:32 AM
Hadasit Bio Holdings Flagship Portfolio Company Enlivex Therapeutics Ltd. Awarded Orphan Drug Status for ApoCell, Inc. Treatment by the FDA 4/4/2013 10:18:21 AM
ApoCell, Inc.'s Circulating Tumor Cell (CTC) Capture Technology First to Reliably Detect and Recover Deadly Liver Cancer Cells 4/3/2012 9:25:53 AM
ApoCell, Inc. Awarded $2.9 Million from SAIC-Frederick, Inc. (SAI) to Deliver a New Platform for Detection and Molecular Analysis of Circulating Tumor Cells (CTCs) to the National Cancer Institute’s Pharmacodynamics Program 8/10/2011 10:31:50 AM
Summit Partners Invests in ApoCell, Inc., a Leading Innovative Cancer Diagnostics Company 9/30/2009 10:55:35 AM